Document is current
Any future updates will be listed below
-
Authors
Nakai, Takehiro https://orcid.org/0000-0003-0588-9518
Honda, Nanase
Soga, Eri
Fukui, Sho
Kitada, Ayako
Yokogawa, Naoto
Okada, Masato
- License Information
-
More Information
Article History
Received: 24 July 2023
Accepted: 27 December 2023
First Online: 4 January 2024
Declarations
:
: The study complies with the Declaration of Helsinki. The study was approved by the Ethics Committee of St. Luke’s International Hospital (approval No. 22-R077).
: Written informed consent was obtained from all participants.
: NY received speaking fees from Bristol-Myers Squibb, Chugai Pharmaceutical, GlaxoSmithKline K.K., Mitsubishi Tanabe Pharma, Ono Pharmaceutical Co., Ltd, and Asahi Kasei Pharma.MO received speaking fees and/or honoraria from Eli Lilly and Company, Santen Pharmaceutical, Mitsubishi Tanabe Pharma, Pfizer, and Abbott, Japan. The other authors have no conflicts of interest to declare.
